Related Experiment Videos
Endogenous opioids and neural cancer: an immunoelectron microscopic study
1Department of Anatomy, M.S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Brain Research Bulletin
|June 1, 1989
Summary
[Met5]-enkephalin, an endogenous opioid, inhibits cancer cell replication. This study reveals its specific localization within neuroblastoma cells, offering insights into opioid modulation of neoplasia and tumor growth.
Area of Science:
- Neuroscience
- Oncology
- Cell Biology
Background:
- [Met5]-enkephalin, derived from proenkephalin A, acts as an endogenous opioid peptide.
- It functions as a natural trophic factor, inhibiting cell replication and influencing tumorigenic events.
- Understanding the role of endogenous opioids in neoplasia modulation is crucial.
Purpose of the Study:
- To investigate the fine structural association of enkephalin with cellular components in tumor cells.
- To examine how endogenous opioids modulate neoplasia at a cellular level.
Main Methods:
- Immunoelectron microscopy was employed using antibodies specific to [Met5]-enkephalin-like substances.
- Murine S20Y neuroblastoma cells, known for opioid responsiveness, were utilized.
- Cellular localization and distribution of enkephalin were analyzed.
Main Results:
- Enkephalin immunoreactivity was detected throughout the neuroblastoma cell body and processes.
- Localization included association with the plasma membrane, outer nuclear envelope, and various organelles.
- The nucleus was generally non-reactive, except for specific aggregates near the inner nuclear envelope.
Conclusions:
- Growth-related enkephalins exhibit discrete localization within neuroblastoma cells.
- These findings highlight the intracellular distribution of enkephalins involved in cell replication.
- Further research is needed to elucidate the distinct traffic patterns and actions of enkephalins in neuroblastoma.